Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, Inc. (KYMR), sold 24,942 shares at $87.75 ($2.2M) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Seasonal sale ($2.2M) by Chief Financial Officer — this insider has traded KYMR in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.75 | 2,039 | $179K | 8.2% |
| 2 | $87.75 | 2,039 | $179K | 8.2% |
| 3 | $88.50 | 1,424 | $126K | 5.8% |
| 4 | $88.50 | 1,424 | $126K | 5.8% |
| 5 | $89.66 | 4,113 | $369K | 16.9% |
| 6 | $89.66 | 4,113 |
| $369K |
| 16.9% |
| 7 | $84.00 | 492 | $41K | 1.9% |
| 8 | $84.00 | 492 | $41K | 1.9% |
| 9 | $85.04 | 2,519 | $214K | 9.8% |
| 10 | $85.04 | 2,519 | $214K | 9.8% |
| 11 | $85.78 | 1,437 | $123K | 5.6% |
| 12 | $85.78 | 1,437 | $123K | 5.6% |
| 13 | $86.62 | 447 | $39K | 1.8% |
| 14 | $86.62 | 447 | $39K | 1.8% |
| Total | $87.50 avg | 24,942 | $2.2M | 100% |
| Filing → |
| KYMR | SELL | 2025-03-03 | $389K | — | Filing → |
| KYMR | SELL | 2024-03-04 | $318K | — | Filing → |
| KYMR | SELL | 2023-03-03 | $42K | — | Filing → |